Secondary Stroke Prevention

AF detection and treatment matters

About Medtronic

WHO WE ARE
At Medtronic, we believe in the power of medical technology to improve lives. Seven decades ago, our co-founder invented the battery-powered pacemaker. Today, we are among the largest medical device companies in the world.

With operations in 150 countries, our products treat 70 health conditions and include cardiac devices, cranial and spine robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Our therapies help 72 million people a year and support our Mission to alleviate pain, restore health, and extend life.

Our people make it possible. We value diverse perspectives and encourage our 90,000+ employees to be themselves. We hold each other accountable, act with integrity, and make quality our highest priority.

We are privileged to be part of the communities where we live and work. We are committed to giving back and reducing our impact on the environment.

Let’s take healthcare Further, Together.

Learn more on our website.

Download Our Brochure

THE LINQ BETWEEN CRYPTOGENIC STROKE AND AF
Atrial fibrillation detection and treatment matters for improved stroke outcomes

CONTACTING MEDTRONIC

Call Steven Wasserman, Sales Rep, (516) 557-4100 or email: steven.wasserman@medtronic.com